The Evolving Landscape for Complement Therapeutics in Rheumatic and Autoimmune Diseases

Area of Science:

• Immunology
• Pathogenesis of autoimmune diseases

Background:

• The complement system plays a significant role in inflammatory and autoimmune diseases.
• Commercial efforts are expanding to develop novel complement inhibitors and pathway-modulating drugs.

Purpose of the Study:

• To review the evolving understanding of complement system components and activation pathways.
• To discuss complement dysregulation in target tissues and its role in various diseases.
• To outline approved and developing complement therapeutics for rheumatic and non-rheumatic diseases.

Main Methods:

• Review of scientific literature on complement system biology and therapeutics.
• Analysis of complement activation mechanisms in specific diseases (rheumatoid arthritis, lupus, thrombotic microangiopathies).
• Discussion of therapeutic strategies and biomarker studies for complement assessment.

Main Results:

• The complement system's central role in disease pathogenesis is increasingly recognized.
• Successful development of complement therapeutics highlights its importance.
• Specific mechanisms of complement activation are detailed for key diseases.

Conclusions:

• Understanding complement pathways is vital for developing effective treatments for autoimmune and inflammatory conditions.
• Complement therapeutics offer promising treatment options for a range of diseases.
• Biomarker studies are essential for personalized assessment of complement system function.